Investigating how protein changes in the eye lens lead to cataracts
Exploring Crystallin Deamidation as a Causative Agent of Cataracts
This study is looking at how changes in certain proteins in the eye can lead to cataracts, with the hope of finding new ways to prevent them from forming, so people who can't have surgery can still keep their vision.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California-Irvine NIH-funded |
| Lab location | 1 site (Irvine, United States) |
| Project ID | NIH-10893350 on NIH RePORTER |
What this research studies
This research focuses on understanding how specific changes in proteins called crystallins contribute to the formation of cataracts, which can cause blindness. By studying the effects of deamidation, a chemical modification that alters protein structure, the research aims to uncover the mechanisms behind protein aggregation in the eye lens. The goal is to develop new therapeutic strategies that could prevent cataracts from forming, offering an alternative to the current surgical treatment. This could potentially improve access to care for individuals who cannot undergo surgery due to healthcare limitations.
Who could benefit from this research
Good fit: Ideal candidates for this research include older adults who are at risk of developing cataracts due to age-related changes in the eye.
Not a fit: Patients with cataracts who are not eligible for new therapeutic interventions or who require immediate surgical treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that prevent cataracts, reducing the need for surgery and improving vision for many patients.
How similar studies have performed: Previous research has shown promise in understanding protein modifications related to cataract formation, indicating that this approach could lead to meaningful advancements.
Where this research is happening
Irvine, United States
- University of California-Irvine — Irvine, United States (Active)
Researchers
- Principal investigator: Rocha, Megan — University of California-Irvine
- Study coordinator: Rocha, Megan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.